2026

NUSMed Trailblazer Research Series: “Pioneering Global Impact in Cancer Research” by CSI Singapore Director, Prof. Ashok Venkitaraman

What does it mean to pioneer global impact in cancer research? In this video, CSI Singapore Director, Prof. Ashok Venkitaraman reflects on discoveries in genome stability and the BRCA2 gene, and

NUSMed Trailblazer Research Series: “Pioneering Global Impact in Cancer Research” by CSI Singapore Director, Prof. Ashok Venkitaraman Read More »

Pembrolizumab Plus Lenvatinib in Recurrent Gynaecological Clear Cell Carcinoma (LARA): A Multicentre, Single-Arm, Phase 2 Trial (The LANCET Oncology, Feb 2026)

A multinational study led by Principal Investigator A/Prof. David Tan and collaborators from Singapore and South Korea has demonstrated encouraging results for patients with recurrent clear cell ovarian and endometrial

Pembrolizumab Plus Lenvatinib in Recurrent Gynaecological Clear Cell Carcinoma (LARA): A Multicentre, Single-Arm, Phase 2 Trial (The LANCET Oncology, Feb 2026) Read More »